샘플 요청 목록

 카트 문의
시장보고서
상품코드
1793000

세계의 액체 크로마토그래피 질량분석(LC-MS) 시장

Liquid Chromatography-Mass Spectroscopy (LC-MS)
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 273 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 액체 크로마토그래피 질량분석(LC-MS) 시장은 2030년까지 112억 달러에 이를 전망

2024년에 63억 달러로 추정되는 액체 크로마토그래피 질량분석(LC-MS) 세계 시장은 분석 기간인 2024-2030년 CAGR 10.1%로 성장하여 2030년에는 112억 달러에 이를 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 Triple Quadrupole LC-MS는 CAGR 9.3%를 나타내고, 분석 기간 종료까지 62억 달러에 이를 것으로 예측됩니다. Ion trap LC-MS 부문의 성장률은 분석 기간중 CAGR 10.9%로 추정됩니다.

미국 시장은 17억 달러로 추정, 중국은 CAGR13.6%로 성장 예측

미국의 액체 크로마토그래피 질량분석(LC-MS) 시장은 2024년에 17억 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2030년까지 23억 달러 규모에 이를 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 13.6%로 추정됩니다. 기타 주목해야 할 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 7.4%와 8.9%를 보일 것으로 예측됩니다. 유럽에서는 독일이 CAGR 7.9%를 나타낼 전망입니다.

세계의 액체 크로마토그래피 질량분석(LC-MS) 시장 - 주요 동향과 촉진요인 정리

LC-MS가 복잡한 분석 용도의 표준이 되고 있는 이유는 무엇인가?

LC-MS로 널리 알려진 액체 크로마토그래피 질량 분석법은 과학 및 산업 분야의 광범위한 분야에서 가장 강력하고 필수적인 분석 기술 중 하나가 되었습니다. 액체 크로마토그래피의 물리적 분리 능력과 질량 분석기의 질량 분석 능력을 결합하여 LC-MS는 혼합물 내 복잡한 화합물의 정확한 식별, 정량 및 구조 해명을 가능하게 합니다. 이 기술은 의약품 개발, 바이오마커 탐색, 임상 진단, 단백질체학, 대사체학, 환경 검사에서 핵심적인 역할을 하고 있습니다. 고감도, 고처리량 분석법에 대한 요구가 높아지면서 기존 기술로는 동일한 수준의 분리능과 정확도를 달성할 수 없는 작업에 LC-MS 시스템을 채택하는 실험실이 증가하고 있습니다. 제약 산업에서 LC-MS는 미량 수준의 불순물이나 대사물을 검출할 수 있어 신약개발, 약동학, 품질관리에 많이 활용되고 있습니다. 임상검사실에서는 치료제물 모니터링, 만성질환 및 감염성 질환의 바이오마커 검출에 LC-MS가 활용되고 있습니다. 식품 안전 및 환경 검사 기관은 오염물질, 잔류물, 독소를 고감도로 검출하기 위해 LC-MS를 사용하고 있습니다. 학술 연구, 특히 시스템 생물학 및 개인 맞춤형 의료 분야에서도 이 기술의 혜택을 누리고 있습니다. LC-MS의 다목적성과 신뢰성은 이온화 기술 및 소프트웨어 통합의 끊임없는 혁신과 함께 다양한 분야에서 정밀한 분자 분석법으로서의 역할을 확고히 하고 있습니다.

기술 발전은 LC-MS 시스템의 능력을 어떻게 확장하고 있는가?

하드웨어와 소프트웨어의 기술 발전은 LC-MS 시스템의 기능, 효율성 및 사용자 접근성을 획기적으로 향상시켰습니다. 비행시간형(TOF), 오비트랩, 사중극자 기술 등 고해상도 질량분석기의 개발로 분석 대상물의 검출과 특성 분석에 있어 이전과는 비교할 수 없는 정밀도와 민감도를 연구자들에게 제공합니다. 이러한 개선을 통해 복잡한 동중량체 화합물의 분리, 번역 후 변형의 식별, 극히 적은 양의 화합물이 포함된 시료의 분석이 가능해졌습니다. 동시에 초고속 액체 크로마토그래피(UHPLC) 기능을 갖춘 향상된 크로마토그래피 시스템은 더 날카로운 피크와 높은 처리량으로 더 빠른 분리를 가능하게 했습니다. 시료 준비의 자동화와 로봇의 통합은 실험실과 상업용 실험실 모두에서 인적 오류를 줄이고 워크플로우의 속도를 높이고 있습니다. 소프트웨어 측면에서는 사용자 친화적인 인터페이스, 클라우드 연결, AI 기반 데이터 처리 도구를 통해 실시간 분석, 예측 모델링, 보다 직관적인 데이터 시각화를 가능하게 합니다. 이러한 발전은 LC-MS의 민주화에 기여하여 숙련된 과학자들이 요구하는 견고한 분석 기준을 유지하면서 전문가가 아니더라도 LC-MS를 보다 쉽게 이용할 수 있도록 하고 있습니다. 또한, 환경 모니터링, 법의학 조사, 현장 의약품 품질 검사 등 현장 기반 용도를 위해 소형화된 휴대용 LC-MS 장비가 개발되고 있습니다. 전기분무 이온화(ESI) 및 매트릭스 지원 레이저 탈이온화(MALDI)와 같은 이온원 설계의 혁신은 효과적으로 분석할 수 있는 분자의 범위를 넓히고 있습니다. 이러한 기술적 향상으로 인해 LC-MS의 도입이 촉진되어 이전에는 실용적이지 않거나 비용적으로 어려웠던 새로운 용도의 개발이 가능해졌습니다.

LC-MS의 채용을 형성하는 업계 동향과 분야별 요구사항은 무엇인가?

산업 전반에 걸친 LC-MS의 보급은 규제 요건의 변화, 연구 요구의 진화, 분석 대상의 복잡성 증가에 의해 촉진되고 있습니다. 제약 분야에서는 생물학적 제제, 바이오시밀러, 저분자 화합물의 보다 신속하고 정밀한 특성 분석에 대한 요구가 제약 개발 파이프라인의 각 단계에 LC-MS의 통합을 촉진하고 있습니다. 규제 기관은 점점 더 상세한 불순물 프로파일링 및 구조 해명을 요구하고 있으며, LC-MS는 규정 준수 및 승인을 위한 중요한 도구가 되고 있습니다. 임상 진단 분야에서는 개인 맞춤형 의료로 인해 특이성이 높은 바이오마커 검출과 약리유전체 프로파일링에 대한 수요가 증가하고 있으며, 이는 모두 LC-MS 플랫폼의 민감도와 선택성에 의존하고 있습니다. 음료 및 식품 업계도 잔류농약, 마이코톡신, 식품첨가물의 실시간 검사에 LC-MS를 활용하여 소비자의 안전과 규제와의 정합성을 보장하고 있습니다. 환경 모니터링 기관은 LC-MS를 활용하여 대기, 물, 토양의 오염물질을 정확하게 평가하여 오염과 생태계 건강에 대한 전 세계의 우려에 대응하고 있습니다. 학계와 연구기관은 유전체학, 대사체학, 질병 병리학의 다학제적 연구를 지원하기 위해 LC-MS의 역량을 확장하고 있습니다. 또한, 법의학에서는 분석 정확도가 가장 중요한 독물학, 약물 검사, 범죄 수사를 위해 LC-MS가 채택되고 있습니다. 이러한 분야별 동향은 고유한 이용 사례에 맞춘 특수 LC-MS 키트 및 프로토콜의 개발로 뒷받침되고 있으며, 시장 침투를 더욱 촉진하고 있습니다. 과학계가 분자 탐색 및 진단의 한계에 계속 도전하는 가운데, LC-MS는 혁신과 컴플라이언스를 실현하는 중요한 수단으로 성장하고 있는 다양한 분야에서 두각을 나타내고 있습니다.

세계 LC-MS 시장 성장 가속화의 주요 요인은?

액체 크로마토그래피 질량 분석 시장의 성장은 분석 요구 사항의 복잡성과 과학적 및 규제적 과제 증가를 반영하는 몇 가지 상호 연관된 요인에 의해 주도되고 있습니다. 가장 큰 촉진요인 중 하나는 LC-MS가 연구개발 및 품질 보증 활동 모두에 필수적인 제약 분야의 응용 기반이 확대되고 있다는 점입니다. 보다 효율적이고 개인화된 헬스케어의 추진은 임상 진단에 대한 수요를 촉진하고 있으며, 검사실은 질병 감지, 치료 모니터링, 바이오마커 검증을 위한 보다 정확한 툴을 요구하고 있습니다. 생명과학 연구, 특히 유전체학, 단백질체학, 대사체학에 대한 자금 지원이 증가함에 따라 LC-MS와 같은 고해상도 분석 플랫폼에 대한 지속적인 수요가 발생하고 있습니다. 전 세계 규제 기관은 식품 안전, 환경 규정 준수, 의약품 제조 등의 분야에서 기준을 강화하고 있으며, LC-MS는 이러한 요구 사항을 충족하는 데 필수적인 역할을 하고 있습니다. 신흥국에서는 의료 인프라, 학술 연구, 산업 품질 관리에 대한 투자가 LC-MS 공급업체에게 새로운 시장 기회를 제공합니다. 사용 편의성 개선, 운영 비용 절감, 처리량 향상 등의 기술 발전은 소규모 실험실 및 분산형 검사 시설에 LC-MS를 더욱 매력적으로 만들고 있습니다. 또한, LC-MS 시스템과 실험실 정보 관리 시스템(LIMS) 및 자동화 플랫폼의 통합은 워크플로우의 효율성을 높이고 더 광범위한 채택을 가능하게 합니다. 장비 제조업체, 소프트웨어 개발자, 최종 사용자 간의 전략적 협업을 통해 특정 산업 요구에 맞는 솔루션 개발이 가속화되고 있습니다. 마지막으로, 의약품 개발 수탁기관(CRO) 및 제3자 검사기관의 등장으로 다양한 분석 과제에 대응할 수 있는 범용성 높은 고성능 LC-MS 장비에 대한 수요가 증가하고 있습니다. 이 모든 힘이 세계 LC-MS 시장의 강력하고 지속적인 상승 궤도에 기여하고 있습니다.

부문

유형(Triple Quadrupole LC-MS, Ion trap LC-MS, Single Quadrupole LC-MS), 최종 사용(제약 및 바이오 기업 최종 사용, 병원 및 연구소 최종 사용, 학술기관 및 연구기관 최종 사용)

조사 대상 기업 예

  • Agilent Technologies
  • Analytik Jena GmbH
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • Cleaver Scientific Ltd
  • Danaher Corporation
  • FOSS Analytical
  • Hitachi High-Tech Corporation
  • JEOL Ltd.
  • LECO Corporation
  • Merck KGaA
  • PerkinElmer Inc.
  • Restek Corporation
  • SCIEX
  • Shimadzu Corporation
  • Skyray Instrument Co., Ltd.
  • Thermo Fisher Scientific Inc.
  • VWR International(Avantor)
  • Waters Corporation
  • Wyatt Technology Corporation

AI 통합

Global Industry Analysts는 유효한 전문가 컨텐츠와 AI툴에 의해서, 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 일반적인 LLM나 업계별 SLM 쿼리에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 대량 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수익원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트(UAE)
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 25.08.26

Global Liquid Chromatography-Mass Spectroscopy (LC-MS) Market to Reach US$11.2 Billion by 2030

The global market for Liquid Chromatography-Mass Spectroscopy (LC-MS) estimated at US$6.3 Billion in the year 2024, is expected to reach US$11.2 Billion by 2030, growing at a CAGR of 10.1% over the analysis period 2024-2030. Triple Quadrupole LC-MS, one of the segments analyzed in the report, is expected to record a 9.3% CAGR and reach US$6.2 Billion by the end of the analysis period. Growth in the Ion trap LC-MS segment is estimated at 10.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.7 Billion While China is Forecast to Grow at 13.6% CAGR

The Liquid Chromatography-Mass Spectroscopy (LC-MS) market in the U.S. is estimated at US$1.7 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$2.3 Billion by the year 2030 trailing a CAGR of 13.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.4% and 8.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.9% CAGR.

Global Liquid Chromatography-Mass Spectroscopy (LC-MS) Market - Key Trends & Drivers Summarized

Why Is LC-MS Emerging as the Gold Standard in Complex Analytical Applications?

Liquid Chromatography-Mass Spectroscopy, widely known as LC-MS, has become one of the most powerful and indispensable analytical techniques across a broad range of scientific and industrial fields. By combining the physical separation capabilities of liquid chromatography with the mass analysis capabilities of mass spectrometry, LC-MS enables precise identification, quantification, and structural elucidation of complex compounds within mixtures. This technology plays a central role in pharmaceutical development, biomarker discovery, clinical diagnostics, proteomics, metabolomics, and environmental testing. The growing demand for sensitive and high-throughput analytical methods is pushing laboratories to adopt LC-MS systems for tasks that traditional techniques cannot accomplish with the same level of resolution or accuracy. In the pharmaceutical industry, LC-MS is heavily used for drug discovery, pharmacokinetics, and quality control due to its ability to detect trace levels of impurities and metabolites. Clinical laboratories rely on LC-MS for monitoring therapeutic drugs and detecting biomarkers for chronic and infectious diseases. Food safety and environmental testing agencies use LC-MS to detect contaminants, residues, and toxins with high sensitivity. Academic research is also benefiting from the technology, particularly in the fields of systems biology and personalized medicine. The versatility and reliability of LC-MS, coupled with continuous innovations in ionization techniques and software integration, are solidifying its role as the go-to method for precise molecular analysis across multiple disciplines.

How Are Technological Advancements Expanding the Capabilities of LC-MS Systems?

Technological progress in both hardware and software is dramatically enhancing the capabilities, efficiency, and user accessibility of LC-MS systems. Developments in high-resolution mass analyzers, such as time-of-flight (TOF), orbitrap, and quadrupole technologies, are providing researchers with unprecedented accuracy and sensitivity in detecting and characterizing analytes. These improvements have made it possible to resolve complex isobaric compounds, identify post-translational modifications, and analyze samples with extremely low abundance compounds. Simultaneously, enhanced chromatographic systems with ultra-high performance liquid chromatography (UHPLC) capabilities allow for faster separations with sharper peaks and higher throughput. Automation in sample preparation and robotic integration is reducing human error and speeding up workflows in both research and commercial laboratories. On the software front, user-friendly interfaces, cloud connectivity, and AI-powered data processing tools are enabling real-time analysis, predictive modeling, and more intuitive data visualization. These advancements are helping to democratize LC-MS, making it more accessible to non-experts while maintaining the robust analytical standards demanded by seasoned scientists. Additionally, miniaturized and portable LC-MS instruments are being developed for field-based applications, such as environmental monitoring, forensic investigations, and on-site pharmaceutical quality testing. Innovations in ion source design, such as electrospray ionization (ESI) and matrix-assisted laser desorption ionization (MALDI), are expanding the scope of molecules that can be effectively analyzed. Together, these technological improvements are driving greater adoption of LC-MS and enabling new applications that were previously impractical or cost-prohibitive.

What Industry Trends and Sector-Specific Demands Are Shaping LC-MS Adoption?

The widespread adoption of LC-MS across industries is being driven by changing regulatory requirements, evolving research needs, and the rising complexity of analytical targets. In the pharmaceutical sector, the demand for faster and more precise characterization of biologics, biosimilars, and small molecules is prompting companies to integrate LC-MS into every stage of the drug development pipeline. Regulatory bodies are increasingly mandating detailed impurity profiling and structural elucidation, making LC-MS a critical tool for compliance and approval. In the clinical diagnostics arena, personalized medicine is generating demand for highly specific biomarker detection and pharmacogenomic profiling, both of which rely on the sensitivity and selectivity of LC-MS platforms. The food and beverage industry is also turning to LC-MS for real-time testing of pesticide residues, mycotoxins, and food additives, ensuring consumer safety and regulatory alignment. Environmental monitoring agencies are utilizing LC-MS to assess air, water, and soil contaminants with precision, responding to global concerns over pollution and ecological health. Academic institutions and research organizations are expanding their LC-MS capabilities to support interdisciplinary studies in genomics, metabolomics, and disease pathology. Additionally, the forensic sciences have adopted LC-MS for toxicology, drug testing, and criminal investigations where analytical precision is paramount. These sector-specific trends are supported by the development of specialized LC-MS kits and protocols tailored to unique use cases, further driving market penetration. As the scientific community continues to push the boundaries of molecular discovery and diagnostics, LC-MS stands out as a critical enabler of innovation and compliance across a growing range of sectors.

What Key Factors Are Driving the Accelerated Growth of the LC-MS Market Worldwide?

The growth in the liquid chromatography-mass spectroscopy market is driven by several interconnected factors that reflect the rising complexity of analytical requirements and the broadening scope of scientific and regulatory challenges. One of the most significant drivers is the expanding application base in pharmaceuticals, where LC-MS is essential for both R&D and quality assurance activities. The push for more efficient and personalized healthcare is also fueling demand in clinical diagnostics, as laboratories seek more accurate tools for disease detection, therapeutic monitoring, and biomarker validation. Increased funding for life sciences research, particularly in genomics, proteomics, and metabolomics, is creating a sustained demand for high-resolution analytical platforms like LC-MS. Regulatory bodies across the globe are tightening standards in areas such as food safety, environmental compliance, and drug manufacturing, making LC-MS indispensable for meeting these requirements. In emerging economies, investments in healthcare infrastructure, academic research, and industrial quality control are creating new market opportunities for LC-MS providers. Technological advancements that improve ease of use, reduce operational costs, and increase throughput are also making LC-MS more attractive to smaller laboratories and decentralized testing facilities. Additionally, the integration of LC-MS systems with laboratory information management systems (LIMS) and automation platforms is enhancing workflow efficiency and enabling broader adoption. Strategic collaborations between instrument manufacturers, software developers, and end-users are accelerating the development of tailored solutions that meet specific industry needs. Finally, the rise of contract research organizations (CROs) and third-party testing labs is boosting demand for versatile, high-performance LC-MS instruments capable of handling a wide variety of analytical challenges. All of these forces are contributing to a strong and sustained upward trajectory in the global LC-MS market.

SCOPE OF STUDY:

The report analyzes the Liquid Chromatography-Mass Spectroscopy (LC-MS) market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Triple Quadrupole LC-MS, Ion trap LC-MS, Single Quadrupole LC-MS); End-Use (Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use, Academic & Research Institutes End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 36 Featured) -

  • Agilent Technologies
  • Analytik Jena GmbH
  • Bio-Rad Laboratories, Inc.
  • Bruker Corporation
  • Cleaver Scientific Ltd
  • Danaher Corporation
  • FOSS Analytical
  • Hitachi High-Tech Corporation
  • JEOL Ltd.
  • LECO Corporation
  • Merck KGaA
  • PerkinElmer Inc.
  • Restek Corporation
  • SCIEX
  • Shimadzu Corporation
  • Skyray Instrument Co., Ltd.
  • Thermo Fisher Scientific Inc.
  • VWR International (Avantor)
  • Waters Corporation
  • Wyatt Technology Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Liquid Chromatography-Mass Spectroscopy (LC-MS) - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Demand for High-Throughput and High-Precision Analytical Techniques Throws the Spotlight on LC-MS Systems
    • Growth in Proteomics, Metabolomics, and Biomarker Discovery Propels Widespread Adoption of LC-MS in Life Sciences
    • Expanding Role of LC-MS in Clinical Diagnostics Strengthens Business Case for Integrated and Automated Systems
    • Advancements in High-Resolution and Triple Quadrupole Technologies Improve Sensitivity and Selectivity in Complex Analyses
    • Widespread Use in Pharmaceutical QA/QC and Drug Development Accelerates Investment in Robust LC-MS Platforms
    • Integration of LC-MS in Environmental and Food Safety Testing Spurs Adoption Across Government and Industrial Labs
    • Automation and Miniaturization Trends Enhance Throughput and Reduce Operational Complexity in LC-MS Workflows
    • Rising Incidence of Chronic and Infectious Diseases Fuels Use of LC-MS in Therapeutic Drug Monitoring and Pathogen Detection
    • Omics-Based Research and Personalized Medicine Initiatives Throw the Spotlight on Multi-Omic LC-MS Applications
    • Cloud-Enabled Data Analysis and AI Integration Improve Interpretation and Workflow Efficiency for LC-MS Operators
    • Global Expansion of Research Infrastructure and Academic Funding Supports Increased LC-MS Utilization
    • Growth of Biologics and Biosimilars Markets Drives Need for LC-MS in Structural and Impurity Characterization
    • Point-of-Care and Portable LC-MS Innovations Expand Opportunities Beyond Centralized Laboratory Settings
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Liquid Chromatography-Mass Spectroscopy (LC-MS) Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Triple Quadrupole LC-MS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Triple Quadrupole LC-MS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Triple Quadrupole LC-MS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Ion trap LC-MS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Ion trap LC-MS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Ion trap LC-MS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Single Quadrupole LC-MS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Single Quadrupole LC-MS by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Single Quadrupole LC-MS by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Pharma & Biotech Companies End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Pharma & Biotech Companies End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals & Research Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospitals & Research Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Hospitals & Research Laboratories End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Academic & Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Academic & Research Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Academic & Research Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Liquid Chromatography-Mass Spectroscopy (LC-MS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Percentage Breakdown of Value Sales for Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS for the Years 2015, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Percentage Breakdown of Value Sales for Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS for the Years 2015, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
  • JAPAN
    • Liquid Chromatography-Mass Spectroscopy (LC-MS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Percentage Breakdown of Value Sales for Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS for the Years 2015, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
  • CHINA
    • Liquid Chromatography-Mass Spectroscopy (LC-MS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Percentage Breakdown of Value Sales for Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS for the Years 2015, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
  • EUROPE
    • Liquid Chromatography-Mass Spectroscopy (LC-MS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Percentage Breakdown of Value Sales for Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
  • FRANCE
    • Liquid Chromatography-Mass Spectroscopy (LC-MS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Percentage Breakdown of Value Sales for Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS for the Years 2015, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
  • GERMANY
    • Liquid Chromatography-Mass Spectroscopy (LC-MS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Percentage Breakdown of Value Sales for Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS for the Years 2015, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Percentage Breakdown of Value Sales for Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS for the Years 2015, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Liquid Chromatography-Mass Spectroscopy (LC-MS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Percentage Breakdown of Value Sales for Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS for the Years 2015, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Percentage Breakdown of Value Sales for Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS for the Years 2015, 2025 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: Spain 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Percentage Breakdown of Value Sales for Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS for the Years 2015, 2025 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Russia 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Percentage Breakdown of Value Sales for Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Liquid Chromatography-Mass Spectroscopy (LC-MS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Percentage Breakdown of Value Sales for Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS for the Years 2015, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Liquid Chromatography-Mass Spectroscopy (LC-MS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Percentage Breakdown of Value Sales for Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS for the Years 2015, 2025 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Australia 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
  • INDIA
    • Liquid Chromatography-Mass Spectroscopy (LC-MS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Percentage Breakdown of Value Sales for Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS for the Years 2015, 2025 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: India 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Percentage Breakdown of Value Sales for Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS for the Years 2015, 2025 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: South Korea 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Percentage Breakdown of Value Sales for Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS for the Years 2015, 2025 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Liquid Chromatography-Mass Spectroscopy (LC-MS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Percentage Breakdown of Value Sales for Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS for the Years 2015, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Percentage Breakdown of Value Sales for Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS for the Years 2015, 2025 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Argentina 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Percentage Breakdown of Value Sales for Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS for the Years 2015, 2025 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Brazil 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Percentage Breakdown of Value Sales for Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS for the Years 2015, 2025 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Mexico 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Percentage Breakdown of Value Sales for Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS for the Years 2015, 2025 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Liquid Chromatography-Mass Spectroscopy (LC-MS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Percentage Breakdown of Value Sales for Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS for the Years 2015, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Percentage Breakdown of Value Sales for Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS for the Years 2015, 2025 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Iran 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Percentage Breakdown of Value Sales for Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS for the Years 2015, 2025 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Israel 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Percentage Breakdown of Value Sales for Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS for the Years 2015, 2025 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Percentage Breakdown of Value Sales for Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS for the Years 2015, 2025 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: UAE 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Percentage Breakdown of Value Sales for Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS for the Years 2015, 2025 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030
  • AFRICA
    • Liquid Chromatography-Mass Spectroscopy (LC-MS) Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by Type - Percentage Breakdown of Value Sales for Triple Quadrupole LC-MS, Ion trap LC-MS and Single Quadrupole LC-MS for the Years 2015, 2025 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Africa 15-Year Perspective for Liquid Chromatography-Mass Spectroscopy (LC-MS) by End-Use - Percentage Breakdown of Value Sales for Pharma & Biotech Companies End-Use, Hospitals & Research Laboratories End-Use and Academic & Research Institutes End-Use for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제